Clinical Trials on Protein Digestion & Absorption in Australia

Total 2119 results

Blade Therapeutics

Completed

First in Human Study in Healthy Volunteers Followed With Dosing in Participants With Lung or Liver Fibrosis

Fibrosis

Australia
The Prince Charles Hospital
National Health and Medical Research Council, Australia

Completed

Desensitising Celiac Disease Patients With the Human Hookworm (NaCeD)

Celiac Disease

Australia
GlaxoSmithKline
Iqvia Pty Ltd

Completed

To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM 6)

Multiple Myeloma

United States, Australia, Spain, United Kingdom, Canada
Alios Biopharma Inc.
Vertex Pharmaceuticals Incorporated

Terminated

First in Human Study of ALS-002158; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

Hepatitis C, Chronic

Australia, New Zealand
Medtronic - MITG

Completed

MACCS: Multicenter Australian CE in Patients With Suspected Crohn's Disease Study (MACCS)

Inflammatory Bowel Diseases

Australia
Griffith Base Hospital

Recruiting

Effect of Enhanced Interactive Text Messages and Phone Instruction on the Quality of Bowel Preparation for Colonoscopy.

Colon Polyp | Colon Neoplasm

Australia
LISCure Biosciences

Completed

A Study to Assess the Safety and Tolerability of LB-P6 and LB-P8 in Healthy Participants

Rheumatoid Arthritis | Non-Alcoholic Steatohepatitis

Australia
Dr Kundan Singh Chufal

Active, not recruiting

Response Prediction to Neoadjuvant Chemoradiation in Esophageal Cancer Using Artificial Intelligence & Machine Learning (QARC)

Esophageal Neoplasm

Australia, India
St Vincent's Hospital Melbourne
Epworth Healthcare

Recruiting

Intraductal Papillary Mucinous Neoplasm (IPMN) Database - A Tool to Predict Pancreatic Cancer (MAPS)

IPMN | IPMN, Pancreatic

Australia
Western Sydney Local Health District

Recruiting

ESD for Colorectal LSL Using a Selective Strategy - a Prospective Cohort Study (COVERT)

Colorectal Neoplasm | Endoscopic Mucosal Resection

Australia
Bayside Health

Completed

Relationship of Vasoactive Peptide Levels to Portal Pressure and Patient Outcomes in Patients With Hepatic Cirrhosis

Portal Hypertension

Australia
St Vincent's Hospital Melbourne
Monash University; The Queen Elizabeth Hospital; The University of Queensland; BiomeBank...

Recruiting

Microbial Restoration in Inflammatory Bowel Diseases (MIRO II)

Inflammatory Bowel Diseases | Crohn Disease | Microbiome | Fecal Microbiota Transplantation

Australia
University of Melbourne

Completed

Post-operative Crohn's Endoscopic Recurrence Study (POCER)

Crohn's Disease

Australia
Syneos Health

Completed

First-in-Human Study of SRT-015 in Healthy Subjects.

Nonalcoholic Steatohepatitis

Australia
iOMEDICO AG
Stemline Switzerland GmbH; Climedo Health GmbH

Recruiting

Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma - SEATTLE- (SEATTLE)

Multiple Myeloma

Austria, Germany
Kirby Institute

Recruiting

Australian Hepatitis and Risk Survey in Prisons (AusHep)

HIV Infections | Hepatitis B | Hepatitis C

Australia
St Vincent's Hospital Melbourne

Completed

The Multi-disciplinary Treatment of Functional Gut Disorders Study (MANTRA)

Functional Dyspepsia | Irritable Bowel Syndrome | Constipation - Functional | Faecal Incontinence | Functional Abdominal Pain Syndrome | Other Rome IV Functional Gastrointestinal Disorders

Australia
Surgical Outcomes Research Centre (SOuRCe)

Recruiting

PRIORITY-CONNECT 2 Pilot Trial

Gastric Cancer | Colorectal Cancer | Pancreas Cancer | Liver Cancer | Oesophageal Cancer

Australia
Kirby Institute

Recruiting

Strategic Treatment Reduction in Very Early Liver Disease With 4 Weeks Sofosbuvir Plus Glecepravir-pibrentasvir (STRIVE-4)

Hepatitis C

Australia
Kirby Institute
Janssen-Cilag Ltd.

Completed

DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C) (DARE-C)

Hepatitis C, Chronic

Australia
Bayside Health

Unknown

The Early Nasojejunal Tube to Meet Energy Requirements in Intensive Care (ENTERIC) Study (ENTERIC)

Critical Illness | Malabsorption Syndromes

Australia
Royal North Shore Hospital

Completed

Predicting RadIotherapy ReSponse of Rectal Cancer With MRI and PET (PRISM)

Rectal Neoplasms

Australia
Liveome Inc.

Recruiting

A Study of LIV001 in Healthy Subjects and Those With Mild-to-Moderate Active Ulcerative Colitis (UC)

Ulcerative Colitis

Australia
KoBioLabs

Withdrawn

A Study to Investigate Efficacy and Safety of KBL697 in Patients With Mild to Moderate Active Ulcerative Colitis

Ulcerative Colitis

Australia
Telethon Kids Institute
Menzies School of Health Research; The University of Western Australia

Terminated

Oral Nitazoxanide in Acute Gastroenteritis in Australian Indigenous Children (NICEGUT)

Gastroenteritis

Australia
Trans Tasman Radiation Oncology Group
Australasian Gastro-Intestinal Trials Group; Colorectal Surgical Society of... and other collaborators

Completed

A Randomised Trial of Preoperative Radiotherapy for Stage T3 Adenocarcinoma of Rectum

Adenocarcinoma of Rectum

Australia, New Zealand
JD Bioscience Inc.
Novotech (Australia) Pty Limited

Enrolling by invitation

First-in-Human Study of GM-60106 in Healthy Adults and Otherwise Healthy Adults With an Increased Body Mass Index and Markers of Non-Alcoholic Fatty Liver Disease

Non-alcoholic Steatohepatitis

Australia
Baxalta now part of Shire

Completed

Efficacy and Safety Study of Augmentation Therapy With ARALAST Fraction IV-1 (Human Alpha 1 - Proteinase Inhibitor)

Alpha 1-Antitrypsin Deficiency

New Zealand, Australia
Royal North Shore Hospital

Active, not recruiting

Liver Function Investigation With SPECT (LiverINSPECT)

Liver Cancer, Adult

Australia
Genzyme, a Sanofi Company

Completed

Phase I FOLFOX Combination

Advanced Colorectal Carcinoma

Australia
Medical University Innsbruck

Recruiting

CRP Apheresis in STEMI

ST Elevation Myocardial Infarction | Myocardial Injury | Apheresis | C-Reactive Protein

Austria, Germany
Hoffmann-La Roche

Completed

A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer

Liver Cancer

Hong Kong, Taiwan, Singapore, Australia
Monash University
The Alfred; University of Melbourne

Recruiting

Human Papillomavirus in Young People Epidemiological Research 4 (HYPER4)

Cancer | Anal Cancer | HPV Infection | HPV | Human Papillomavirus Infection | Men | HPV 16 Infection

Australia
Monash University
The Alfred; University of Melbourne

Recruiting

Human Papillomavirus in Young People Epidemiological Research 3 (HYPER3)

Cancer | Anal Cancer | HPV Infection | HPV | Human Papillomavirus Infection | Men | HPV 16 Infection

Australia
Kirby Institute

Active, not recruiting

Study of Pomalidomide in Anal Cancer Precursors (SPACE)

High Grade Squamous Intra-epithelial Lesion (HSIL)

Australia
Baxalta now part of Shire
American Thrombosis and Hemostasis Network; UDC Rare Bleeding and Clotting...

Completed

Ceprotin Treatment Registry

Protein C Deficiency

United States, United Kingdom, Germany, Italy, Netherlands, Austria
Bristol-Myers Squibb

Withdrawn

Multiple Ascending Dose Study of BMS-929075 in Hepatitis C Virus (HCV) Infected Patients

Chronic Hepatitis C

Australia
Medical University of Vienna

Completed

BT200 in Hereditary Bleeding Disorders

Hemophilia A | Von Willebrand Diseases

Austria
Professor Michael Bourke

Recruiting

Australian Barrett's Cohort With Dysplasia and Early Cancer Study (ABCDE)

Barrett's Esophagus

Australia
GC Cell Corporation

Not yet recruiting

Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201

Breast Cancer | Gastric Cancer | Gastroesophageal Junction Adenocarcinoma

Australia
Austin Health
University of Melbourne

Completed

Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis (PREDICT UC)

Ulcerative Colitis

Australia
Huahui Health

Completed

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH-006 in Healthy Volunteers

Hepatitis B

Australia
FixHepC

Unknown

Reviewing DAA Efficacy Managing Patient Treatment In Online Neighbourhoods (REDEMPTION)

Hepatitis C

Australia
The University of Queensland

Completed

Combined Gut-brain Therapy for Children With Autism

Anxiety | Neurodevelopmental Disorders | Functional Gastrointestinal Disorders | Autism Spectrum Disorder

Australia
Accenture

Completed

Single Dose Safety Study for Compound to Treat Post-Operative Nausea and Vomiting (PONV)

Post-Operative Nausea and Vomiting (PONV)

Australia
GlaxoSmithKline

Completed

Japanese Phase I of GSK1605786

Crohn's Disease

Australia
Avidia

Unknown

Phase 1 Study of Safety and Biological Effects of C326, an Inhibitor of IL-6, in Crohn's Disease

Crohn's Disease

Australia
Novartis Pharmaceuticals

Completed

Safety, Efficacy, Dose-finding Study of a Monoclonal Antibody in Patients With Multiple Myeloma

Multiple Myeloma

United States, Australia
Murdoch Childrens Research Institute

Recruiting

Nausea and Vomiting in Postoperative Paediatric Patients With Patient-Controlled Analgesia (PCA): Morphine vs Oxycodone (POPCORN)

Patient-Controlled Analgesia

Australia
North Eastern Weight Loss Surgery
Ethicon Endo-Surgery

Unknown

Outcomes of Gastric Band Fills as Found With a Patient Self-reported Questionnaire: The Vomiting, Eating, and Weight Loss (VEW) Questionnaire

Morbid Obesity

Australia

Clinical Trials on Protein Digestion & Absorption in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations